. 2017 Sep 23;8(50):87737–87749. doi: 10.18632/oncotarget.21209

Table 1. Clinicopathological correlation analysis of miR-526b expression in hepatocellular carcinoma.

Clinicopathologic features		miR-526b expression		P
Clinicopathologic features		High level (n=40)	Low level (n=40)	P
Age (y)	≤50	15	17	0.648
Age (y)	>50	25	23	0.648
Sex	Male	33	35	0.531
Sex	Female	7	5	0.531
HBsAg	No	4	7	0.330
HBsAg	Yes	36	33	0.330
Serum AFP level (ng/mL)	≤20	14	10	0.329
Serum AFP level (ng/mL)	>20	26	30	0.329
Tumor size (cm)	≤5	15	6	0.022^*
Tumor size (cm)	>5	25	34	0.022^*
No. of tumor nodules	1	36	32	0.210
No. of tumor nodules	≥2	4	8	0.210
Cirrhosis	Absent	13	7	0.121
Cirrhosis	Present	27	33	0.121
Venous infiltration	Absent	25	14	0.014^*
Venous infiltration	Present	15	26	0.014^*
Edmondson-Steiner grading	I+II	34	27	0.066
Edmondson-Steiner grading	III+IV	6	13	0.066
TNM tumor stage	I+II	36	29	0.045^*
TNM tumor stage	III+IV	4	11	0.045^*

HBV, hepatitis B virus; AFP, alpha-fetoprotein; TNM, tumor-node-metastasis. ^*Statistically significant.